Modified gold nanoshells might safely target cancer, study finds

02/17/2014 | In-PharmaTechnologist.com

Scientists from East China Normal University and Tongji University have modified gold nanostructures to deliver drugs to cancer cells without harming normal cells by adding a peptide known as A54. The researchers tested the approach on human liver cancer cells, finding the gold nanoshells plus doxorubicin and A54 had greater uptake than the nanoshells with the anticancer drug but no A54. There was also less uptake of both by healthy cells. The gold nanoshell structure also might allow for conversion of near-infrared light into heat, improving hyperthermia treatment. Details of the study appear in the journal Biomedical Materials.

View Full Article in:

In-PharmaTechnologist.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY